SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs >

Spectrum Pharmaceutecals, Inc. (SPPI)

SPPI RSS Feed
Add SPPI Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/24/2017 6:41:23 PM - Followers: 75 - Board type: Free - Posts Today: 0

http://www.spectrumpharm.com/

http://finance.yahoo.com/q/ks?s=SPPI+Key+Statistics

Company Presentation

http://www.sppirx.com/704-corporate-presentation.html

Spectrum Development Pipeline/Portfolio

Fusilev® (Levoleucovorin) for injection FDA Approved on April 29, 2011 for Use in Patients with Advanced Metastatic Colorectal Cancer and FDA Approved on March 7, 2008 for High-Dose Methotrexate Rescue Therapy in Osteosarcoma.
Zevalin® (ibritumomab tiuxetan), an FDA-Approved, Proprietary, Biological Drug for Indolent Non-Hodgkin's Lymphoma.
Belinostat a novel HDAC inhibitor in late stage clinical development for Peripheral T-cell Lymphoma, and other Solid Tumors (including Carcinoma of Unknown Primary, etc.)
Apaziquone, one of our lead development candidates, is a synthetic bio-reductive prodrug that is being investigated in the treatment of non-invasive bladder cancer, and began two Phase 3 studies in 2007.Spectrum also has three drugs in the Phase 2 stage of development: Ozarelix, for the treatment of prostate cancer and Ortataxel, for the treatment of taxane-refractory tumors.
The Company has three drugs in the Phase 1 stage of development: SPI-1620, an adjunct to chemotherapy, Elsamitrucin, which will target advanced solid tumors and Lucanthone, a chemotherapy sensitizer in the treatment of recurrent, malignant brain tumors.
Other drugs in development include SPI-014, used in the treatment of hyperphosphotemia in end stage renal disease (ESRD), and SPI-205 for chemotherapy induced neuropathy.

Recent News (Zevalin):

http://investor.spectrumpharm.com/releasedetail.cfm?ReleaseID=632354
http://investor.spectrumpharm.com/releasedetail.cfm?ReleaseID=632346

.  

 

SPPI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPPI News: Statement of Changes in Beneficial Ownership (4) 07/18/2017 06:03:46 PM
SPPI News: Statement of Changes in Beneficial Ownership (4) 07/18/2017 06:01:43 PM
SPPI News: Confidential Treatment Order (ct Order) 07/12/2017 12:28:34 PM
SPPI News: Statement of Changes in Beneficial Ownership (4) 06/29/2017 06:42:42 PM
SPPI News: Statement of Changes in Beneficial Ownership (4) 06/29/2017 06:42:15 PM
PostSubject
#1703   Significant change to the EGFR Exon 20 Mutation antihama 07/24/17 06:41:23 PM
#1702   It's a Late Breaking Abstract! Per ESMO Late-breaking antihama 07/24/17 06:07:57 PM
#1701   Poziotinib - HANMI Phase II results Just Jack 07/24/17 12:34:45 PM
#1700   Spectrum Pharma vs Nabriva Therapeutics Head-To-Head Comparison. I antihama 07/22/17 12:27:54 PM
#1699   Yeah, it's looking good! antihama 07/20/17 09:37:22 PM
#1698   Just confirming I'm not blowing smoke up my antihama 07/20/17 09:29:07 PM
#1697   We hit the 52 week high this morning, Just Jack 07/20/17 10:21:16 AM
#1696   Another large volume day (1.83M) yesterday w SP antihama 07/14/17 08:05:10 AM
#1695   Large block buy - wish it was me, Just Jack 07/13/17 01:58:30 PM
#1694   Buying of 567000 shares near the end of antihama 07/12/17 06:31:38 PM
#1693   Poziotinib Antihama - thank you for the thoughtful response Just Jack 07/11/17 01:20:50 PM
#1692   What she say? (on technical analysis) If you're antihama 07/10/17 10:43:31 PM
#1691   Hey Just Jack, I agree but w antihama 07/10/17 10:35:12 PM
#1690   One month from hearing 2nd quarter results. Should Just Jack 07/06/17 03:59:21 PM
#1689   LMAO! Article says Spectrum being acquired by Repligen. antihama 06/27/17 06:23:53 PM
#1688   Regarding yesterday's volume spike antihama 06/27/17 06:12:56 PM
#1687   S/P is green in a sea of red antihama 06/27/17 05:50:20 PM
#1686   Dr. Hari's Evomela PK study is now 'Active, antihama 06/27/17 03:13:44 PM
#1685   Final thoughts on the Pralatrexate/Romidepsin abstract and PR. antihama 06/26/17 07:48:53 PM
#1684   Portola’s Bevyxxa fails primary endpoint but is approved! antihama 06/26/17 04:33:08 PM
#1683   "Top 4 Small-Cap Stocks for 2017" Investopedia repost antihama 06/21/17 08:53:46 AM
#1682   PR today on Pralatrexate/Romidepsin in Relapsed/Refractory Lymphoid Malignancies. antihama 06/19/17 08:33:57 AM
#1681   Some thoughts on Puma’s neratinib. The Advisory Panel antihama 06/18/17 10:49:08 AM
#1680   Annual Meeting voting 8k antihama 06/16/17 08:00:37 PM
#1679   Folotyn being tested in combo with PD-L1 inhibitor antihama 06/16/17 06:43:21 PM
#1678   Just commented on an article about Coherus's biosim antihama 06/13/17 02:09:31 PM
#1677   The future playing field/market potential for Rolontis revisited. antihama 06/13/17 01:09:33 PM
#1676   No one wants to go near EGFR Exon antihama 06/09/17 12:15:45 PM
#1675   Pfizer’s EGFR TKI lung cancer candidate, dacomitinib was antihama 06/08/17 09:34:32 PM
#1674   My take on the Jeffries 2017 Global Healthcare antihama 06/06/17 09:48:28 PM
#1673   Zevalin mentioned as an ADC drug being sold antihama 06/02/17 04:26:32 PM
#1672   The future playing field/market potential for Rolontis. An antihama 05/26/17 03:21:42 PM
#1671   Investopedia recommendation of SPPI and the Golden Cross. antihama 05/23/17 07:43:49 AM
#1670   Regarding the combo trial of poziotinib w T-DM1 antihama 05/22/17 05:39:12 PM
#1669   I think we just dodged a bullet. I antihama 05/17/17 10:06:09 PM
#1668   Thanks stugwins. I try to present facts but antihama 05/17/17 03:23:04 PM
#1667   Keep it up antihama. There are plenty who stugwins 05/17/17 02:27:07 PM
#1666   Im reading his posts, just not replying. Didn't Fenway32 05/17/17 01:52:03 PM
#1665   You are essentially talking to yourself as I antihama 05/15/17 04:04:45 PM
#1664   'antihama...I used to be a long term holder pearsby09 05/15/17 03:35:50 PM
#1663   I am not disagreeing with that assumption, after antihama 05/15/17 09:22:28 AM
#1662   You did not consider the Raj discount.....The market stugwins 05/14/17 12:55:51 PM
#1661   Spectrum’s MC is WAY LOW compared to MacroGenics antihama 05/13/17 11:03:04 AM
#1660   Just to clarify, when I refer to 'halted' antihama 05/12/17 08:10:36 AM
#1659   EGFR exon 20 insertions is one tough cookie antihama 05/11/17 09:00:03 PM
#1658   Initially stumped by a new SPI-2012 PK study antihama 05/10/17 06:11:39 PM
#1657   Correction- I didn't mean 'laxative' in the previous antihama 05/06/17 08:40:37 AM
#1656   Tracking the poziotinib dosing changes for my sanity. antihama 05/05/17 02:06:32 PM
#1655   Puma's Senior Vice President, Regulatory Affairs and Project antihama 05/04/17 06:08:28 PM
#1654   Stream of consciousness thoughts on 2017 Q1 CC antihama 05/03/17 10:03:15 AM
PostSubject